Key pharmaceutical company stories.
- Q&A with Elmar Schnee, Head of Pharmaceuticals at Merck KGaA
Elmar Schnee explains Merck KGaA's recent activities in the area of cancer drug development, and discusses the performance of Erbitux.
Oct 3, 2006
- Q&A with Andreas Barner, Head of R&D at Boehringer Ingelheim
Earlier this year, IMS interviewed Andreas Barner, Boehringer's R&D chief, and he discussed the German company's major pipeline project.
Sep 8, 2006
- Q&A with William Burns, CEO Pharmaceuticals Division at Roche
Highlights of an exclusive interview with Roche Pharmaceuticals CEO William Burns, including a discussion of the company's major therapy interests.
Aug 1, 2006
- Q&A with Fred Hassan, CEO Schering-Plough
Edited highlights of an exclusive interview with Schering-Plough CEO Fred Hassan, who discusses the company's turnaround and future growth prospects.
Jul 4, 2006
- New patterns emerge in pharma M&A
The era of the 'mega-merger' may be over - for now - but there is no sign of the pace of deals within the drug industry slowing, even if they are evolving.
Apr 3, 2006
- Western Sumos Wrestle Into Japan
Switzerland's Roche started something of a trend in late 2002, when it completed a strategic transaction with Japanese pharmaceutical manufacturer Chugai, which merged with Roche's local subsidiary, Nippon Roche.
Apr 30, 2004
